Bladder cancer. Clinical practice guidelines in oncology

Area of Science:

• Oncology
• Urology

Background:

• Urothelial tumors encompass a range of diseases with variable prognoses.
• Patients diagnosed with urothelial cancer remain at risk for new or recurrent lesions.

Purpose of the Study:

• To review current and emerging strategies for managing urothelial tumors.
• To highlight advancements in diagnosis, treatment, and monitoring of urothelial cancer.

Main Methods:

• Review of current literature on urothelial tumor management.
• Discussion of evolving treatment modalities including molecular staging, combined-modality therapy, and novel systemic agents.

Main Results:

• Most recurrences are superficial and manageable endoscopically.
• Molecular staging is under development to refine prognosis and guide management.
• Newer surgical and radiation techniques offer improved quality of life and survival for extensive disease.
• Novel agents show promise for metastatic urothelial cancer.

Conclusions:

• Continued monitoring is crucial for early detection of urothelial tumor recurrence.
• Advancements in molecular staging and treatment modalities are expected to significantly improve patient outcomes.
• The treatment landscape for urothelial tumors is rapidly evolving, offering hope for better cure rates and organ preservation.